Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Helicobacter pylori hpaA Protein, N-His

Catalog #:   YXX18701 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P55969
Protein length: Ala53-Arg260
Overview

Catalog No.

YXX18701

Expression system

E. coli

Species

Helicobacter pylori (strain ATCC 700392 / 26695) (Campylobacter pylori)

Protein length

Ala53-Arg260

Predicted molecular weight

25.59 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P55969

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Neuraminyllactose-binding hemagglutinin, Flagellar sheath adhesin, N-acetylneuraminyllactose-binding fibrillar hemagglutinin receptor-binding subunit, NLBH, hpaA, HP_0797

Data Image
References

A potential anti-Helicobacter pylori strategy: Exploring the antibacterial mechanism of organic acids in sea buckthorn (Hippophae rhamnoides L.)., PMID:40073720

Modeling and optimization of culture media for recombinant Helicobacter pylori vaccine antigen HpaA., PMID:39698188

Developing a multi-epitope vaccine against Helicobacter Pylori., PMID:39642777

Association of Antibody Responses to Helicobacter pylori Proteins with Colorectal Adenoma and Colorectal Cancer., PMID:39452767

Candidate Antigens and the Development of Helicobacter pylori Vaccines., PMID:39177204

Real-world evidence of a novel tetravalent immunoglobulin Y effectiveness and safety in patients with the refractory Helicobacter pylori infection., PMID:38937679

Construction and Validation of Chicken Immune scFv Antibody Library against Helicobacter pylori., PMID:38930530

Recombinant L. lactis vaccine LL-plSAM-WAE targeting four virulence factors provides mucosal immunity against H. pylori infection., PMID:38402145

An M cell-targeting recombinant L. lactis vaccine against four H. pylori adhesins., PMID:38396242

Unraveling the crystal structure of the HpaA adhesin: insights into cell adhesion function and epitope localization of a Helicobacter pylori vaccine candidate., PMID:38376163

Embedding of exogenous B cell epitopes on the surface of UreB structure generates a broadly reactive antibody response against Helicobacter pylori., PMID:37899627

A multiserological line assay to potentially discriminate current from past Helicobacter pylori infection., PMID:37827383

Identification and characterization of shark VNARs targeting the Helicobacter pylori adhesin HpaA., PMID:37695066

Helicobacter pylori multiplex serology and risk of non-cardia and cardia gastric cancer: a case-cohort study and meta-analysis., PMID:36913255

Protective immunity enhanced Salmonella vaccine vectors delivering Helicobacter pylori antigens reduce H. pylori stomach colonization in mice., PMID:36466847

Serum antibodies to selected Helicobacter pylori antigens are associated with active gastritis in patients seen at the University Teaching Hospital in Lusaka, Zambia., PMID:37265823

Hesperetin Inhibits Expression of Virulence Factors and Growth of Helicobacter pylori., PMID:34576198

The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer., PMID:34363898

Design, expression, and purification of a multi-epitope vaccine against Helicobacter Pylori based on Melittin as an adjuvant., PMID:34022362

Oral multivalent epitope vaccine, based on UreB, HpaA, CAT, and LTB, for prevention and treatment of Helicobacter pylori infection in C57BL / 6 mice., PMID:33847026

A Novel Multi-Epitopic Peptide Vaccine Candidate Against Helicobacter pylori: In-Silico Identification, Design, Cloning and Validation Through Molecular Dynamics., PMID:33495694

Helicobacter pylori adhesins: HpaA a potential antigen in experimental vaccines for H. pylori., PMID:33259676

Identification of Functional Interactome of Gastric Cancer Cells with Helicobacter pylori Outer Membrane Protein HpaA by HPLC-MS/MS., PMID:32566649

[HpaA promotes gastric mucosa injury via stimulating IL-21 secretion of T cells]., PMID:31638572

[Screening and characterization of nucleic acid aptamers specifically binding to adhesin HpaA from Helicobacter pylori]., PMID:31292058

Synthetic Lipopeptide Enhances Protective Immunity Against Helicobacter pylori Infection., PMID:31258538

Immunoinformatics Approach to Design a Novel Epitope-Based Oral Vaccine Against Helicobacter pylori., PMID:31120321

Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori., PMID:30660182

Intranasal immunization with immunodominant epitope peptides derived from HpaA conjugated with CpG adjuvant protected mice against Helicobacter pylori infection., PMID:30217524

A survey on chimeric UreB229-561-HpaA protein targeting Helicobacter pylori: Computational and in vitro urease activity valuation., PMID:29929167

Protection Against Helicobacter pylori Infection in BALB/c Mouse Model by Oral Administration of Multivalent Epitope-Based Vaccine of Cholera Toxin B Subunit-HUUC., PMID:29867978

Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice., PMID:29299716

Performance of a Multiplex Serological Helicobacter pylori Assay on a Novel Microfluidic Assay Platform., PMID:28972560

Immunologic properties and therapeutic efficacy of a multivalent epitope-based vaccine against four Helicobacter pylori adhesins (urease, Lpp20, HpaA, and CagL) in Mongolian gerbils., PMID:28851031

Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on H. pylori Infection in Mongolian gerbils., PMID:28824883

Crystallization and X-ray analysis of the extracellular adhesion domain of Helicobacter pylori adhesin A: the significance of the cation composition in the crystallization precipitant., PMID:28368278

Fallacy of the Unique Genome: Sequence Diversity within Single Helicobacter pylori Strains., PMID:28223462

Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens., PMID:28215587

Systematic identification of immunodominant CD4+ T cell responses to HpaA in Helicobacter pylori infected individuals., PMID:27509059

Construction of a recombinant Lactococcus lactis strain expressing a fusion protein of Omp22 and HpaA from Helicobacter pylori for oral vaccine development., PMID:27406731

Helicobacter pylori blood biomarker for gastric cancer risk in East Asia., PMID:27170766

Cloning, expression and purification flagellar sheath adhesion of Helicobacter pylori in Escherichia coli host as a vaccination target., PMID:26866020

Multiplex-PCR-Based Screening and Computational Modeling of Virulence Factors and T-Cell Mediated Immunity in Helicobacter pylori Infections for Accurate Clinical Diagnosis., PMID:26287606

Anti-Helicobacter pylori Antibody Profiles in Epstein-Barr virus (EBV)-Positive and EBV-Negative Gastric Cancer., PMID:26251258

Oral administration of recombinant Neisseria meningitidis PorA genetically fused to H. pylori HpaA antigen increases antibody levels in mouse serum, suggesting that PorA behaves as a putative adjuvant., PMID:25750999

[The research on the construction and characteristics of recombinant engineering bacteria with multi-epitope of Helicobacter pylori]., PMID:24941798

Helicobacter pylori antibody patterns in Germany: a cross-sectional population study., PMID:24782915

The rOmp22-HpaA fusion protein confers protective immunity against helicobacter pylori in mice., PMID:23715666

A dominant CD4(+) T-cell response to Helicobacter pylori reduces risk for gastric disease in humans., PMID:23232294

Prospective study of Helicobacter pylori biomarkers for gastric cancer risk among Chinese men., PMID:23035179

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Helicobacter pylori hpaA Protein, N-His [YXX18701]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only